Chromosomal Microarray Testing for the Evaluation of Pregnancy Loss
Customize your policy alerts
Sign up for blue_shield_of_california Policy PHP_2.04.122 alerts
Get alerted when Policy PHP_2.04.122 changes without checking for updates manually.
Monitor payer policy activity
Coverage of chromosomal microarray testing of fetal or placental tissue to evaluate pregnancy loss when policy criteria are met, including qualifying second- or third-trimester intrauterine fetal death when testing may inform future pregnancies.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.